cell-based assays

NEW YORK (GenomeWeb News) – Bioanalytical tools company Hurel raised $9.2 million in a Series A private equity financing round, the North Brunswick, NJ-based company said today.

NEW YORK (GenomeWeb News) – German firm Medicyte today said that it has licensed lentiviral vector technology from Life Technologies for use in developing cell-based assays.

NEW YORK (GenomeWeb News) – Cellectricon today said that it has signed agreement with two firms to distribute its products in Japan.

NEW YORK (GenomeWeb News) – Biotech firm Odyssey Thera has raised $2.8 million and initiated a research service contract with Merck, it announced on Thursday.

NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and Cellular Dynamics today announced a licensing deal allowing CDI to develop, manufacture, and sell cellular assays and models derived from induced pluripotent stem cells for drug discovery and toxicity screening.

NEW YORK (GenomeWeb News) – Cisbio Bioassays today announced a deal to distribute BellBrook Labs' Transcreener Epigen Methyltransferase assay.

NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening. Financial terms of the deal were not disclosed.

NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.